To mark International Women’s Day, we sat down with the CTN 335 investigators to learn about how their research could improve healthy aging for women living with HIV
Learn More
The drug works against CMV, a common virus that may be a main cause of inflammation and health problems in people living with HIV
Learn More
Ahead of World Cancer Day, we spoke with Dr. Troy Grennan about anal cancer screening among gbMSM living with HIV, a population disproportionately affected by the condition
Learn More
In recognition of Bell Let’s Talk Day, we look at what steps can be taken to improve mental health and wellbeing among people affected by HIV
Learn More
CTN 300: The Engage Study is investigating the use of PrEP among urban Canadian gay, bisexual, and other men who have sex with men
Learn More
A new national study, called HIVCOV (CTN 328), will assess COVID-19 vaccine immune responses and effectiveness among people living with HIV
Learn More
A new CTN study investigates how exposure to HIV and antiretroviral drugs during pregnancy could have long-term effects for the millions of kids who were born to mothers living with HIV, but who did not acquire the virus themselves
Learn More
March 31 marks the International Transgender Day of Visibility, an annual event dedicated to celebrating...
Learn More
Here are the seven ways that the CTN works towards the meaningful involvement of people...
Learn More